We apply the portfolio approach as permitted by ASC 606 as a practical expedient to contracts with similar characteristics and we use estimates and assumptions when accounting for those portfolios. Our contracts generally include standard commercial payment terms. We have no significant obligations for refunds, warranties or similar obligations and our revenue does not include taxes collected from our customers. Technology-enabled business solutions: Revenue derived on an on-going basis from our technology- ...

For the quarterly period ended March 31, 2023 Commission File Number 001-36529 Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. Indicate by check mark wh ...

CareCloud, Inc. (NASDAQ:CCLD) Q4 2022 Earnings Conference Call March 2, 2023 8:30 AM ET Company Participants Kimberly Blanche - General Counsel and Vice President of Compliance Mahmud Haq - Founder and Executive Chairman Hadi Chaudhry - Chief Executive Officer, President and Director Bill Korn - Chief Financial Officer Conference Call Participants Jeffery Cohen - Ladenburg Thalmann & Co Allen Klee - Maxim Group Michael Donovan - HC Wainwright & Co. Operator Welcome to the CareCloud, Inc. Fourth Quarter and ...

27 The HITECH and Cures Acts (as described in more detail above) contain certification requirements which affect our business because we have invested and continue to invest in conforming our products and services to these standards. HHS has developed certification programs for electronic health records and health information exchanges. Our web-based EHR solutions have been certified as complete EHR systems by ICSA Labs or Drummond Group, nongovernmental, independent certifying bodies. We must ensure that o ...

CareCloud, Inc. (MTBC) Q3 2022 Results Conference Call November 3, 2022 8:30 AM ET Company Participants Nathalie Garcia - Associate General Counsel & Chief Compliance Officer Mahmud Haq - Founder and Executive Chairman Hadi Chaudhry - CEO, President and Director Bill Korn - CFO Karl Johnson - Chief Growth Officer Conference Call Participants Destiny Alexandra - Ladenburg Thalmann Allen Klee - Maxim Group Marc Wiesenberger - B. Riley Securities Operator Welcome to the CareCloud, Inc. Third Quarter 2022 Resul ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36529 CareCloud, Inc. (Exact name of registrant as specified in its charter) Delaware 22-3832302 (State or other jurisdictio ...

CareCloud, Inc. (MTBC) Q2 2022 Earnings Conference Call August 4, 2022 8:30 AM ET Company Participants A. Hadi Chaudhry – President & CEO Bill Korn – CFO Karl Johnson – President, CareCloud Force Kimberly Blanche – General Counsel and VP of Compliance Mahmud Haq – Founder & Executive Chairman Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Marc Wiesenberger - B. Riley Securities Allen Klee - Maxim Group David Larsen - BTIG Kevin Dede - H.C. Wainwright Operator Welcome to CareCloud's Second Q ...

0 Q2 2022 Results Nasdaq Global Market: MTBC, MTBCP, MTBCO Safe Harbor Statements This presentation contains forward-looking statements within the meaning of the federal securities laws. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as "anticipate", "believe", "continue", "could", "estimate", "expect", "goals", "intend", "likely", "may", "might", "plan", "poten ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36529 CareCloud, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporati ...

Financial Data and Key Metrics Changes - Revenue for Q1 2022 was $35.3 million, representing a 19% year-over-year increase and slightly exceeding expectations [8][24] - Adjusted EBITDA was $4.7 million, reflecting a 28% increase compared to $3.7 million in the previous year [27] - Adjusted net income was $3.5 million, or $0.23 per share, marking a 20% year-over-year increase [27] - GAAP net income improved to $1.1 million from a net loss of $2 million in the previous year [27] - Adjusted EBITDA margin increased to 13.4% from 12.4% year-over-year [28] Business Line Data and Key Metrics Changes - Revenue from technology-enabled solutions accounted for 85% of total revenue, with 48% from core technology suite clients, 15% from clients using additional components, and 22% from IT services [24] - Revenue growth was significantly driven by medSR, which achieved record revenue during Q1 and increased its backlog [26] Market Data and Key Metrics Changes - The sales pipeline increased nearly 50% year-over-year to $22 million, with total pipeline standing at approximately $40 million at quarter end [18][19] - Enterprise accounts represented 50% of the pipeline improvement, up from 36% in the previous year [20] - Force program contributed 10% to pipeline growth, a fivefold increase year-over-year [21] Company Strategy and Development Direction - The company aims to become a leading technology and solution supplier to healthcare providers, focusing on innovation and cross-selling opportunities [9] - New products launched include CareCloud Remote and CareCloud Wellness, targeting home health and chronic care management markets [10][12] - The Force initiative is designed to create partnerships rather than acquisitions, enhancing service offerings and revenue potential [14][15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving 2022 targets, citing strong early results and a healthy sales pipeline [22][21] - The company anticipates a normal seasonal cadence in revenue, with Q2 expected to show increased activity compared to Q1 [40] - Management noted that the enterprise deals, while taking longer to close, offer higher margins and better growth opportunities [62] Other Important Information - The company ended Q1 with $10.1 million in cash and generated $3.1 million in cash flow from operations [29] - Guidance for 2022 remains unchanged, with expected revenue between $152 million and $155 million [30] Q&A Session Summary Question: Size of the commercial team and efficiencies - The U.S. team consists of approximately 32 resources, with an additional 22 on the digital marketing side, and plans to hire more senior positions [34] Question: Growth drivers from CareCloud Force - The Force program has seen a fivefold increase in opportunities, with a significant increase in bookings for Q1 [36][37] Question: Anticipated top line for the year - Revenue is expected to follow a normal seasonal pattern, with Q2 showing more activity and Q3 being the peak [40] Question: Positioning of CareCloud Wellness - CareCloud Wellness is positioned as a risk-free model for existing clients, with no additional operational expenses [45][46] Question: Dynamics of medSR's revenue - medSR had a strong quarter, contributing positively to overall revenue, while the core business remained roughly flat [51] Question: Changes in sales cycles - Enterprise deals may take longer to close but offer better long-term growth opportunities [62] Question: R&D expenditure run rate - R&D expenses are expected to remain constant, with some fluctuations based on product development stages [65] Question: Competitive wins in the university segment - Recent wins in the university segment are expected to lead to broader adoption of CareCloud's platform [53][69]